Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Multi-rotor wake characterization and visualization in ascending and descending flight

    This study employs wind tunnel experiments to investigate the wake characteristics of multi-rotor unmanned air vehicles in ascending and descending vertical flight modes. First, flow visualization is used to o...

    G. Throneberry, A. Takeshita, C. M. Hocut, F. Shu, A. Abdelkefi in Experiments in Fluids (2022)

  2. No Access

    Chapter and Conference Paper

    Impacts of Test Fixture Connections of the BARC Structure on Its Dynamical Responses

    The Box Assembly with Removable Component (BARC) structure has been recently introduced as a challenge problem for the study of the effects of boundary conditions on vibrational testing and modal analysis. Cur...

    K. Jankowski, H. Sedillo, A. Takeshita in Sensors and Instrumentation, Aircraft/Aero… (2022)

  3. No Access

    Chapter and Conference Paper

    Experimental and Computational Investigations on Fixture Interference for BARC Systems

    For most dynamical systems, there is much uncertainty for boundary conditions between experiments, simulations, and service environments. The Box Assembly with Removable Component attempts to investigate these...

    A. Takeshita, H. Sedillo, K. Jankowski in Sensors and Instrumentation, Aircraft/Aero… (2022)

  4. Article

    Open Access

    Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

    Although tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis of chronic myeloid leukemia (CML), the ability of TKIs to eradicate CML remains uncertain and patients must continue TKI the...

    E Togasaki, J Takeda, K Yoshida, Y Shiozawa, M Takeuchi, M Oshima in Blood Cancer Journal (2017)

  5. No Access

    Article

    Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

    To clarify the cooperative roles of recurrently identified mutations and to establish a more precise risk classification system in acute myeloid leukemia (AML), we comprehensively analyzed mutations in 51 gene...

    R Kihara, Y Nagata, H Kiyoi, T Kato, E Yamamoto, K Suzuki, F Chen, N Asou in Leukemia (2014)

  6. No Access

    Article

    Nella malattia di Cushing da macroadenoma invasivo la bassa espressione della O(6)-metilguanina-DNA-metiltransferasi è frequente

    A. Takeshita, N. Inoshita, M. Taguchi, C. Okuda, N. Fukuhara, K. Oyama in L’Endocrinologo (2010)

  7. Article

    Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells

    Correction to: Leukemia (2009) 23, 1329–1336; doi:10.1038/leukemia.2009.77; published online 16 April 2009 Since the publication of this paper, the authors have noticed an error in Figure 1. The correct figure...

    A Takeshita, N Yamakage, K Shinjo, T Ono, I Hirano, S Nakamura, K Shigeno in Leukemia (2009)

  8. No Access

    Article

    CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells

    We studied the effect of CMC-544, the calicheamicin-conjugated anti-CD22 monoclonal antibody, used alone and in combination with rituximab, analyzing the quantitative alteration of target molecules, that is, C...

    A Takeshita, N Yamakage, K Shinjo, T Ono, I Hirano, S Nakamura, K Shigeno in Leukemia (2009)

  9. No Access

    Article

    ZD6474 induces growth arrest and apoptosis of human leukemia cells, which is enhanced by concomitant use of a novel MEK inhibitor, AZD6244

    C Nishioka, T Ikezoe, A Takeshita, J Yang, T Tasaka, Y Yang, Y Kuwayama in Leukemia (2007)

  10. No Access

    Article

    Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells

    Acute promyelocytic leukemia (APL) cells express a considerable level of CD33, which is a target of gemtuzumab ozogamicin (GO), and a significantly lower level of P-glycoprotein (P-gp). In this study, we exami...

    A Takeshita, K Shinjo, K Naito, H Matsui, N Sahara, K Shigeno, T Horii in Leukemia (2005)

  11. No Access

    Article

    Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys

    In-stent restenosis results exclusively from neointimal hyperplasia due to mechanical injury and a foreign body response to the prosthesis. Inflammation mediated by monocyte chemoattractant protein-1 (MCP-1) m...

    K Ohtani, M Usui, K Nakano, Y Kohjimoto, S Kitajima, Y Hirouchi, X-H Li in Gene Therapy (2004)

  12. No Access

    Article

    Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia

    A Takeshita, A Uehara, K Shinjo, K Naito, N Sahara, K Yamazaki, H Katoh in Leukemia (2004)

  13. No Access

    Article

    Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits

    Early growth response factor-1 (Egr-1) is a transcription factor that is rapidly activated after vascular injury and thus might contribute to vascular proliferation and inflammation. We hypothesized that Egr-1...

    K Ohtani, K Egashira, M Usui, M Ishibashi, K-I Hiasa, Q Zhao, M Aoki in Gene Therapy (2004)

  14. No Access

    Article

    P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelocytic leukemia cells

    A Takeshita, K Shinjo, K Naito, H Matsui, K Shigeno, S Nakamura, T Horii in Leukemia (2003)

  15. No Access

    Article

    Serum lipid profiles in Japanese women and men during consumption of walnuts

    Objective: To determine the serum cholesterol, apolipoproteins and LDL oxidizability in young Japanese women and men during walnut consumption and to evaluate its active principle.

    M Iwamoto, K Imaizumi, M Sato, Y Hirooka, K Sakai in European Journal of Clinical Nutrition (2002)

  16. No Access

    Article

    Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

    Gemtuzumab ozogamicin (CMA-676), a calicheamicin-conjugated humanized anti-CD33 mouse monoclonal antibody, has recently been introduced clinically as a promising drug for the treatment of patients with acute m...

    H Matsui, A Takeshita, K Naito, K Shinjo, K Shigeno, M Maekawa, Y Yamakawa in Leukemia (2002)

  17. No Access

    Article

    Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

    Recent studies have shown that arsenic trioxide (As2O3) can induce complete remission in patients with acute promyelocytic leukemia (APL). We tested the efficacy and safety of As2O3 for the treatment of patients ...

    K Ohnishi, H Yoshida, K Shigeno, S Nakamura, S Fujisawa, K Naito, K Shinjo in Leukemia (2002)

  18. No Access

    Article

    Obesity, body fat distribution and coronary atherosclerosis among Japanese men and women

    OBJECTIVE: To investigate the relation of the obesity and body-fat distribution with angiographically defined coronary atherosclerosis.

    K Tanaka, H Kodama, S Sasazuki, K Yoshimasu, Y Liu in International Journal of Obesity (2001)

  19. No Access

    Article

    In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity and reduction in WT1 gene expression

    Interleukin-12 (IL-12) has potent antitumor activities. We examined whether IL-12 enhanced the cytotoxicity of peripheral blood mononuclear cells (PBMNC) and decreased leukemia cells in 30 patients with leukem...

    L Pan, K Ohnishi, WJ Zhang, H Yoshida, L Maksumova, F Muratkhodjaev, K Shigeno in Leukemia (2000)

  20. No Access

    Article

    Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin

    Lovastatin, a competitive inhibitor of HMG-CoA reductase, reportedly inhibits proliferation and induces apoptosis of tumor cells with MDR-1 coded P-glycoprotein (Pgp) expression. In this study we investigated ...

    L Maksumova, K Ohnishi, F Muratkhodjaev, W Zhang, L Pan, A Takeshita, R Ohno in Leukemia (2000)

previous disabled Page of 2